Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
OIOxford IBD Cohort InvestigatorsNRNathaniel R. WestANAhmed N. HegazyBMBenjamin M. J. OwensSJSamuel J. Bullers
University of Oxford · Janssen (United States) · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
788
total citations
- FWCI
- 53.55
- Percentile
- 100%
- References
- 67
Citations per year
Authors
26- OIOxford IBD Cohort InvestigatorsCorresponding
University of Oxford
- NRNathaniel R. West
University of Oxford
- ANAhmed N. Hegazy
University of Oxford
- BMBenjamin M. J. Owens
University of Oxford
- SJSamuel J. Bullers
University of Oxford, Janssen (United States)
Topics & keywords
Topics
Keywords
- Medicine
- Inflammatory bowel disease
- Inflammation
- Tumor necrosis factor alpha
- Oncostatin M
- Disease
- Tumor necrosis factor α
- Necrosis
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.